The Model-based Approach
During ISOP 2022, Hans Langendijk presented the Model-based Approach. Watch the webinar above.
During ISOP 2022, Hans Langendijk presented the Model-based Approach. Watch the webinar above.
The Northwestern Medicine Chicago Proton Center, the advanced cancer care center, has offered proton therapy treatments to patients using IBA’s Proteus®PLUS...
Published in the Green Journal, the PTCOG lymphoma subcommittee conducted a systematic review on available dosimetric studies comparing IMPT free breathing (FB)...
This is a study protocol details a randomized trial taking place in Thailand with multiple centers comparing IMPT and IMRT for stage II–IVA squamous thoracic...
163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...
The Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care...
This symposium held at the 2023 National Proton Conference covers the advantages of DynamicARC proton therapy treatment, and how it is sharper, faster, and...
This study reported the incidence of lymphopenia in 271 stage III NSCLC patients treated with IMPT (n=71) vs IMRT (n=200) and concurrent chemotherapy. The...
To compare the oncologic outcomes between proton therapy and intensity-modulated radiation therapy (IMRT) for head and neck squamous cell carcinoma (HNSCC)...